Abstract
The pharmacokinetic profile of bretylium was studied in four normal male volunteers using a new sensitive EC-GC procedure for its quantitation in biological fluids. The plasma concentrations and urinary excretion rates following the constant i.v. infusion of a single 4mg/kg dose of bretylium tosylate declined biexponentially and the data were fitted to a two-compartment model with a renal and a nonrenal route of elimination. The drug had a mean half-life (t1/2β)of 7.8 hr and apparent volume of distribution (Vd,β)of 8.18 liters/kg. The renal clearance, which was 6 times that of the glomerular filtration rate, accounted for almost 84% of the total body clearance and correlated linearly with the subjects' creatinine clearance. The observed side effects of bretylium were mild and similar to those of other adrenergic blocking agents.
Similar content being viewed by others
References
A. L. A. Boura and A. F. Green. Darenthin: Hypotensive agent of new type.Lancet 2:17–21 (1959.
M. B. Bacaner. Bretylium tosylate for suppression of induced ventricular fibrillation.Am. J. Cardiol. 17:528–534 (1966).
C. T. Dollery, D. Emslie-Smith, and J. McMichael. Bretylium tosylate in the treatment of hypertension.Lancet 1:296–299 (1960).
W. G. Duncombe and A. McCoubrey. The excretion and stability to metabolism of bretylium.Br. J. Pharmacol. 15:260–264 (1960).
R. Kuntzman, I. Tsai, R. Chang, and A. H. Conney. Disposition of bretylium in man and rat: A sensitive chemical method for its estimation in plasma and urine.Clin. Pharmacol. Ther. 11:829–837 (1970).
J. Koch-Weser. Drug therapy: Bretylium.New Engl. J. Med. 300:473 (1979).
J. Adir, P. K. Narang, J. Josselson, and J. Sadler. Pharmacokinetics of bretylium in patients with impaired renal function.New Engl. J. Med. 300:1390–1391 (1979).
C. M. Lai, B. L. Kamath, J. E. Carter, P. Erhardt, Z. M. Look, and A. Yacobi. Determination of bretylium in biological fluids. Personal communication.
Berman and Weiss.SAAM Manual, U.S. Department of Health, Education, and Welfare, Washington, D.C., 1978.
H. G. Boxenbaum, S. Riegelman, and R. M. Elashoff. Statistical estimations in pharmacokinetics.J. Pharmacokin. Biopharm. 2:123–148 (1974).
C. Daniel and F. S. Wood.Fitting Equations to Data, Wiley-Interscience, New York, 1971.
Author information
Authors and Affiliations
Additional information
This work was supported in part by a grant from Arnar-Stone Laboratories, Inc., McGaw Park, Illinois.
Rights and permissions
About this article
Cite this article
Narang, P.K., Adir, J., Josselson, J. et al. Pharmacokinetics of bretylium in man after intravenous administration. Journal of Pharmacokinetics and Biopharmaceutics 8, 363–372 (1980). https://doi.org/10.1007/BF01059384
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01059384